GSK (LON:GSK – Get Free Report) had its price objective lifted by investment analysts at Berenberg Bank from GBX 1,650 ($20.84) to GBX 1,820 ($22.99) in a report released on Wednesday, Marketbeat Ratings reports. The firm currently has a “buy” rating on the stock. Berenberg Bank’s price objective indicates a potential upside of 9.44% from […]